Drew Moghanaki

Title(s)Professor-in-Residence, Radiation Oncology
SchoolMedicine
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Drew Moghanaki, M.D., M.P.H., holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The History and Future of Multidisciplinary Cancer Care. Semin Radiat Oncol. 2024 Oct; 34(4):441-451. LaVigne AW, Doss VL, Berizzi D, Johnston FM, Kiess AP, Kirtane KS, Moghanaki D, Roumeliotis M, Yang GQ, Viswanathan AN. PMID: 39271279.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors. Oncologist. 2024 Sep 25. Sebastian NT, Stokes WA, Behera M, Jiang R, Gutman DA, Huang Z, Burns A, Sukhatme V, Lowe MC, Ramalingam SS, Sukhatme VP, Moghanaki D. PMID: 39321212.
      View in: PubMed   Mentions:    Fields:    
    3. Centralized Quality Assurance of Stereotactic Body Radiation Therapy for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer (VALOR). Pract Radiat Oncol. 2024 Sep 02. Ritter TA, Timmerman RD, Hanfi HI, Shi H, Leiner MK, Feng H, Skinner VL, Robin LM, Odle C, Amador G, Sindowski T, Snodgrass AJ, Huang GD, Reda DJ, Slatore C, Sears CR, Cornwell LD, Karas TZ, Harpole DH, Palta J, Moghanaki D. PMID: 39233006.
      View in: PubMed   Mentions: 1     Fields:    
    4. Letter to the Editor in Response to "Adherence to Annual Lung Cancer Screening in a Centralized Academic Program". Clin Lung Cancer. 2024 Aug 30. Wu J, Thomas T, Tavalire HF, Vecchio F, Kyriakides TC, Crothers K, Kelley MJ, Moghanaki D, Shofer S, Hendler F, Feldman L. PMID: 39277443.
      View in: PubMed   Mentions:    Fields:    
    5. Evaluation of chest CT-scans following lung stereotactic ablative radiotherapy: Challenges and new insights. Lung Cancer. 2024 Jul; 193:107848. De Bruycker A, Schneiders F, Gulstene S, Moghanaki D, Louie A, Palma D, Senan S. PMID: 38908164.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung Cancer. JTO Clin Res Rep. 2024 Jul; 5(7):100690. Nikitas J, Yanagawa J, Sacks S, Hui EK, Lee A, Deng J, Abtin F, Suh R, Lee JM, Toste P, Burt BM, Revels SL, Cameron RB, Moghanaki D. PMID: 39077624; PMCID: PMC11284817.
      View in: PubMed   Mentions:
    7. Salvage percutaneous high-dose-rate brachyablation after stereotactic body radiation therapy for early-stage non-small cell lung cancer. J Contemp Brachytherapy. 2024 Apr; 16(2):150-155. Wu TC, Lee A, Suh R, Oughourlian TC, Abtin F, Hagio MA, Park SJ, Chang AJ, Moghanaki D. PMID: 38808204; PMCID: PMC11129647.
      View in: PubMed   Mentions:
    8. Lung Cancer Survival Trends in the Veterans Health Administration. Clin Lung Cancer. 2024 May; 25(3):225-232. Moghanaki D, Taylor J, Bryant AK, Vitzthum LK, Sebastian N, Gutman D, Burns A, Huang Z, Lewis JA, Spalluto LB, Williams CD, Sullivan DR, Slatore CG, Behera M, Stokes WA. PMID: 38553325; PMCID: PMC11098707.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Sub-lobar resections for peripheral non-small cell lung cancer measuring ≤ 2 cm: Insights from recent clinical trials. Radiother Oncol. 2024 03; 192:110094. Senan S, Schneiders FL, Moghanaki D. PMID: 38224918.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. MR-LINAC, a New Partner in Radiation Oncology: Current Landscape. Cancers (Basel). 2024 Jan 08; 16(2). Ocanto A, Torres L, Montijano M, Rincón D, Fernández C, Sevilla B, Gonsalves D, Teja M, Guijarro M, Glaría L, Hernánz R, Zafra-Martin J, Sanmamed N, Kishan A, Alongi F, Moghanaki D, Nagar H, Couñago F. PMID: 38254760; PMCID: PMC10813892.
      View in: PubMed   Mentions: 1  
    11. Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2024 Mar 15; 118(4):963-970. Edwards DM, Sankar K, Alseri A, Jiang R, Schipper M, Miller S, Dess K, Strohbehn GW, Elliott DA, Moghanaki D, Ramnath N, Green MD, Bryant AK. PMID: 37793573.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Unresectable Stage III NSCLC Should Not be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection. J Thorac Oncol. 2023 09; 18(9):1129-1133. Moghanaki D, Lisberg A, Oh S, Lee JM. PMID: 37599046.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Rural barriers and facilitators of lung cancer screening program implementation in the veterans health administration: a qualitative study. Front Health Serv. 2023; 3:1209720. Lewis JA, Bonnet K, Schlundt DG, Byerly S, Lindsell CJ, Henschke CI, Yankelevitz DF, York SJ, Hendler F, Dittus RS, Vogus TJ, Kripalani S, Moghanaki D, Audet CM, Roumie CL, Spalluto LB. PMID: 37674596; PMCID: PMC10477991.
      View in: PubMed   Mentions:
    14. Predicting Overall Survival for Patients with Malignant Mesothelioma Following Radiotherapy via Interpretable Machine Learning. Cancers (Basel). 2023 Aug 01; 15(15). Wang Z, Li VR, Chu FI, Yu V, Lee A, Low D, Moghanaki D, Lee P, Qi XS. PMID: 37568732; PMCID: PMC10416916.
      View in: PubMed   Mentions:
    15. The Association of Organizational Readiness With Lung Cancer Screening Utilization. Am J Prev Med. 2023 11; 65(5):844-853. Lewis JA, Samuels LR, Weems J, Park D, Winter R, Lindsell CJ, Callaway-Lane C, Audet C, Slatore CG, Wiener RS, Dittus RS, Kripalani S, Yankelevitz DF, Henschke CI, Moghanaki D, Matheny ME, Vogus TJ, Roumie CL, Spalluto LB. PMID: 37224985; PMCID: PMC10592591.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib. JTO Clin Res Rep. 2023 Mar; 4(3):100468. Smith CP, Xiang M, Yoon SM, Lee A, Ruan D, Goldman JW, Cummings AL, Lisberg A, Garon EB, Moghanaki D. PMID: 36923158; PMCID: PMC10009282.
      View in: PubMed   Mentions: 2  
    17. The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Clin Lung Cancer. 2023 05; 24(3):287-294. Sebastian NT, Stokes WA, Behera M, Jiang R, Gutman DA, Huang Z, Burns A, Sukhatme V, Lowe MC, Ramalingam SS, Sukhatme VP, Moghanaki D. PMID: 36804711.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    18. Using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME) to study adaptations in lung cancer screening delivery in the Veterans Health Administration: a cohort study. Implement Sci Commun. 2023 Jan 12; 4(1):5. Strayer TE, Spalluto LB, Burns A, Lindsell CJ, Henschke CI, Yankelevitz DF, Moghanaki D, Dittus RS, Vogus TJ, Audet C, Kripalani S, Roumie CL, Lewis JA. PMID: 36635719; PMCID: PMC9836333.
      View in: PubMed   Mentions: 3  
    19. Sins of omission: A meta-research study evaluating the omission of operability in published retrospective comparisons of surgery with stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer. Lung Cancer. 2023 Jan; 175:57-59. Lorenz J, Moghanaki D, Keshava H, Harpole DH, Bradley JD, Higgins KA, Rusthoven CG, Stokes WA. PMID: 36455397.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME) to study lung cancer screening adaptations in the Veterans Health Administration. Res Sq. 2022 Aug 08. Strayer TE, Spalluto LB, Burns A, Lindsell CJ, Henschke CI, Yankelevitz DF, Moghanaki D, Dittus RS, Vogus TJ, Audet C, Kripalani S, Roumie CL, Lewis JA. PMID: 35982653; PMCID: PMC9387539.
      View in: PubMed   Mentions:
    21. De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer. Eur J Cancer. 2022 08; 171:55-63. Bryant AK, Sankar K, Zhao L, Strohbehn GW, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. PMID: 35704975; PMCID: PMC10508975.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer. Cancer Med. 2023 01; 12(1):358-367. Stokes WA, Behera M, Jiang R, Gutman DA, Huang Z, Burns A, Sebastian NT, Sukhatme V, Lowe MC, Ramalingam SS, Sukhatme VP, Moghanaki D. PMID: 35607930; PMCID: PMC9844615.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. Development of a new adapted QuinteT Recruitment Intervention (QRI-Two) for rapid application to RCTs underway with enrolment shortfalls-to identify previously hidden barriers and improve recruitment. Trials. 2022 Apr 04; 23(1):258. Donovan JL, Jepson M, Rooshenas L, Paramasivan S, Mills N, Elliott D, Wade J, Reda D, Blazeby JM, Moghanaki D, Hwang ES, Davies L. PMID: 35379301; PMCID: PMC8978173.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    24. Characterizing Twitter Influencers in Radiation Oncology. Adv Radiat Oncol. 2022 Nov-Dec; 7(6):100919. Valle LF, Chu FI, Smith M, Wang C, Lee P, Moghanaki D, Chino FL, Steinberg ML, Raldow AC. PMID: 35694034; PMCID: PMC9184867.
      View in: PubMed   Mentions: 3  
    25. Outcomes following radical prostatectomy or external beam radiation for veterans with Gleason 9 and 10 prostate cancer. Cancer Med. 2022 08; 11(15):2886-2895. Chao HH, Soni PD, Dahman B, Stilianoudakis SC, Ford H, Singh R, Freedland SJ, Moghanaki D, Vapiwala N, Chang MG. PMID: 35289111; PMCID: PMC9359878.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus? Int J Radiat Oncol Biol Phys. 2022 Mar 01; 112(3):586-589. Swaminath A, Ritter T, Louie AV, Palma DA, Guckenberger M, Senan S, Bezjak A, Moghanaki D. PMID: 35101193.
      View in: PubMed   Mentions: 1     Fields:    
    27. Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer. Cancers (Basel). 2022 Jan 26; 14(3). Sankar K, Bryant AK, Strohbehn GW, Zhao L, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. PMID: 35158881; PMCID: PMC8833364.
      View in: PubMed   Mentions: 14  
    28. Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer. Clin Lung Cancer. 2022 05; 23(3):e231-e237. Stokes WA, Xiong N, Liu Y, Higgins KA, Tian S, Bradley JD, Moghanaki D, Rusthoven CG. PMID: 35093293; PMCID: PMC9106833.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration. J Am Coll Radiol. 2022 01; 19(1 Pt B):131-138. Spalluto LB, Lewis JA, Samuels LR, Callaway-Lane C, Matheny ME, Denton J, Robles JA, Dittus RS, Yankelevitz DF, Henschke CI, Massion PP, Moghanaki D, Roumie CL. PMID: 35033300; PMCID: PMC8830608.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs. Chest. 2022 03; 161(3):833-844. Syed YA, Stokes W, Rupji M, Liu Y, Khullar O, Sebastian N, Higgins K, Bradley JD, Curran WJ, Ramalingam S, Taylor J, Sancheti M, Fernandez F, Moghanaki D. PMID: 34785235; PMCID: PMC8941602.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer. Adv Radiat Oncol. 2021 Nov-Dec; 6(6):100803. McCall NS, Liu Y, Patel SA, Hershatter B, Moghanaki D, Godette KD, Hanasoge S, Patel P, Fischer-Valuck BW, Shelton JW, Jani AB. PMID: 34703954; PMCID: PMC8526773.
      View in: PubMed   Mentions: 3  
    32. Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer. Brachytherapy. 2021 Nov-Dec; 20(6):1130-1138. Dhere VR, Fischer-Valuck BW, Goyal S, Liu Y, Morgan TM, Ghavidel E, Moghanaki DM, Hershatter BW, Patel PR, Jani AB, Godette KD, Rossi PJ, Patel SA. PMID: 34417136.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation. Radiat Oncol. 2021 Jun 07; 16(1):99. Yoon SM, Suh R, Abtin F, Moghanaki D, Genshaft S, Kamrava M, Drakaki A, Liu S, Venkat P, Lee A, Chang AJ. PMID: 34098977; PMCID: PMC8186067.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    34. Use and Outcomes of SBRT for Early Stage NSCLC Without Pathologic Confirmation in the Veterans Health Care Administration. Adv Radiat Oncol. 2021 Jul-Aug; 6(4):100707. Wilkie JR, Lipson R, Johnson MC, Williams C, Moghanaki D, Elliott D, Owen D, Atluri N, Jolly S, Chapman CH. PMID: 34409207; PMCID: PMC8361048.
      View in: PubMed   Mentions: 2  
    35. An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer. Adv Radiat Oncol. 2021 Mar-Apr; 6(2):100653. Rulach R, Ball D, Chua KLM, Dahele M, De Ruysscher D, Franks K, Gomez D, Guckenberger M, Hanna GG, Louie AV, Moghanaki D, Palma DA, Peedell C, Salem A, Siva S, Videtic GMM, Chalmers AJ, Harrow S. PMID: 33851065; PMCID: PMC8022147.
      View in: PubMed   Mentions: 9  
    36. Organizational Readiness for Lung Cancer Screening: A Cross-Sectional Evaluation at a Veterans Affairs Medical Center. J Am Coll Radiol. 2021 Jun; 18(6):809-819. Spalluto LB, Lewis JA, Stolldorf D, Yeh VM, Callaway-Lane C, Wiener RS, Slatore CG, Yankelevitz DF, Henschke CI, Vogus TJ, Massion PP, Moghanaki D, Roumie CL. PMID: 33421372; PMCID: PMC8180484.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. The Regimen of Computed Tomography Screening for Lung Cancer: Lessons Learned Over 25 Years From the International Early Lung Cancer Action Program. J Thorac Imaging. 2021 Jan; 36(1):6-23. Henschke CI, Yip R, Shaham D, Zulueta JJ, Aguayo SM, Reeves AP, Jirapatnakul A, Avila R, Moghanaki D, Yankelevitz DF, I-ELCAP Investigators. PMID: 32520848; PMCID: PMC7771636.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    38. Protocol to evaluate an enterprise-wide initiative to increase access to lung cancer screening in the Veterans Health Administration. Clin Imaging. 2021 May; 73:151-161. Lewis JA, Spalluto LB, Henschke CI, Yankelevitz DF, Aguayo SM, Morales P, Avila R, Audet CM, Prusaczyk B, Lindsell CJ, Callaway-Lane C, Dittus RS, Vogus TJ, Massion PP, Limper HM, Kripalani S, Moghanaki D, Roumie CL. PMID: 33422974; PMCID: PMC8479827.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy. JAMA Netw Open. 2020 12 01; 3(12):e2025143. Patel SA, Goyal S, Liu Y, Moghanaki D, Patel PR, Hanasoge S, Dhere VR, Shelton JW, Godette KD, Jani AB, Hershatter B, Fischer-Valuck BW. PMID: 33301015; PMCID: PMC7729429.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Prophylactic cranial irradiation or MRI surveillance for extensive stage small cell lung cancer. J Thorac Dis. 2020 Oct; 12(10):6225-6233. Taylor JM, Rusthoven CG, Moghanaki D. PMID: 33209461; PMCID: PMC7656401.
      View in: PubMed   Mentions: 3  
    41. Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial. Front Oncol. 2020; 10:1686. Ricco A, Mukhopadhyay N, Deng X, Holdford D, Skinner V, Saraiya S, Moghanaki D, Anscher MS, Chang MG. PMID: 32974208; PMCID: PMC7471868.
      View in: PubMed   Mentions: 2  
    42. Longitudinal Health-related Quality of Life among Individuals Considering Treatment for Stage I Non-Small-Cell Lung Cancer. Ann Am Thorac Soc. 2020 08; 17(8):988-997. Nugent SM, Golden SE, Hooker ER, Sullivan DR, Thomas CR, Deffebach ME, Sukumar MS, Schipper PH, Tieu BH, Moghanaki D, Wisnivesky J, Samson P, Robinson C, Slatore CG. PMID: 32433897.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    43. Strategic Initiatives for Veterans with Lung Cancer. Fed Pract. 2020 Aug; 37(Suppl 4):S76-S80. Moghanaki D, Hagan M. PMID: 32908355; PMCID: PMC7473723.
      View in: PubMed   Mentions: 3  
    44. Authors' response. Brachytherapy. 2020 Jul - Aug; 19(4):555. Kahn JM, Moghanaki D. PMID: 32674913.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. The Quality of Peer-Reviewed Publications on Surgery for Early Stage Lung Cancer Within the Veterans Health Administration. Semin Thorac Cardiovasc Surg. 2020 Winter; 32(4):1066-1073. Welp AM, Abbott SE, Samson P, Cameron RB, Cornwell LD, Harpole D, Moghanaki D. PMID: 32433987.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Radiotherapeutic Care of Patients With Stage IV Lung Cancer with Thoracic Symptoms in the Veterans Health Administration. Fed Pract. 2020 May; 37(Suppl 2):S38-S42. Gutt R, Malhotra S, Moghanaki D, Cheuk AV, Hoffman-Hogg L, Kelly M, Fosmire H, Dawson G. PMID: 32952386; PMCID: PMC7497879.
      View in: PubMed   Mentions: 1  
    47. Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic. J Thorac Oncol. 2020 07; 15(7):1137-1146. Kumar S, Chmura S, Robinson C, Lin SH, Gadgeel SM, Donington J, Feliciano J, Stinchcombe TE, Werner-Wasik M, Edelman MJ, Moghanaki D. PMID: 32360578; PMCID: PMC7194660.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsPHPublic Health
    48. Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation. Brachytherapy. 2020 Mar - Apr; 19(2):228-233. Kahn J, Dahman B, McLaughlin C, Kapoor P, Kapoor R, Harris E, Sharma M, Schutzer M, Moghanaki D. PMID: 32085930.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. Assessing the Variability and Quality of Lung Stereotactic Radiation Therapy Treatment Plans Using a Web-Based Crowdsourcing Platform. Pract Radiat Oncol. 2020 May - Jun; 10(3):e118-e127. Moghanaki D, Slotman B, Swaminath A, Nelms B, Wang B. PMID: 31837477.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    50. Local consolidative therapy for oligometastatic patients with stage IV non-small cell lung cancer may improve survival, but unanswered questions remain. Transl Lung Cancer Res. 2019 Dec; 8(Suppl 4):S407-S411. Pacheco JM, Moghanaki D. PMID: 32038926; PMCID: PMC6987340.
      View in: PubMed   Mentions:
    51. The current and future landscape of radiotherapy for lung cancer. Transl Lung Cancer Res. 2019 Sep; 8(Suppl 2):S122-S123. Louie AV, Bahig H, Moghanaki D. PMID: 31673515; PMCID: PMC6795580.
      View in: PubMed   Mentions: 3  
    52. Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer. Prostate Cancer Prostatic Dis. 2019 12; 22(4):633-635. Moghanaki D, Howard LE, De Hoedt A, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ. PMID: 31036926; PMCID: PMC6819236.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    53. Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer. Curr Oncol Rep. 2019 03 27; 21(5):43. Kothari G, Ost P, Cheung P, Blanchard P, Tree AC, van As NJ, Lo SS, Moghanaki D, Loblaw A, Siva S. PMID: 30919165.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Safeguarding Autonomy of Patients With Bladder Cancer. Int J Radiat Oncol Biol Phys. 2019 01 01; 103(1):81-83. Yerramilli D, Moghanaki DM, Efstathiou JA. PMID: 30563669.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. Collaborating to assess the role of stereotactic body radiation therapy in medically operable stage I non-small cell lung cancer. J Thorac Dis. 2018 Sep; 10(Suppl 26):S3311-S3313. Cornwell LD, Moghanaki D. PMID: 30370147; PMCID: PMC6186645.
      View in: PubMed   Mentions:
    56. Quality Improvements of Veterans Health Administration Radiation Oncology Services Through Partnership for Accreditation With the ACR. J Am Coll Radiol. 2018 Dec; 15(12):1732-1737. Kapoor R, Moghanaki D, Rexrode S, Monzon B, Ray M, Hulick PR, Albuquerque K, Rosenthal SA, Palta JR, Hagan MP. PMID: 30100162.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin. Am J Clin Oncol. 2018 06; 41(6):544-548. Anscher MS, Chang MG, Moghanaki D, Rosu M, Mikkelsen RB, Holdford D, Skinner V, Grob BM, Sanyal A, Wang A, Mukhopadhyay ND. PMID: 27438691; PMCID: PMC5247423.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    58. Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features. JAMA Oncol. 2018 05 10; 4(5):e175230. Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA. PMID: 29372236; PMCID: PMC5885162.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    59. Management of metastatic spinal cord compression among Veterans Health Administration radiation oncologists. Ann Palliat Med. 2018 Apr; 7(2):234-241. Gutt R, Malhotra S, Jolly S, Moghanaki D, Cheuk AV, Fosmire H, Kelly M, Hoffman-Hogg L, Lutz S, Anscher M, Dawson G, Veterans Health Administration Palliative Radiotherapy Task Force. PMID: 29764185.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    60. The great debate flashes: surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer. Eur J Cardiothorac Surg. 2018 02 01; 53(2):295-305. Weder W, Moghanaki D, Stiles B, Siva S, Rocco G. PMID: 29309549.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey. Adv Radiat Oncol. 2018 Apr-Jun; 3(2):125-129. Lammers A, Mitin T, Moghanaki D, Thomas CR, Timmerman R, Golden SE, Thakurta S, Dziadziuszko R, Slatore CG. PMID: 29904736; PMCID: PMC6000198.
      View in: PubMed   Mentions: 2  
    62. The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer. J Thorac Cardiovasc Surg. 2018 Jan; 155(1):429-431. Moghanaki D, Simone CB, Rimner A, Karas TZ, Donington J, Shirvani SM, Daly M, Videtic GM, Movsas B, ASTRO Evidence-Based Guideline Committee for Stereotactic Body Radiation Therapy (SBRT) for Early-St. PMID: 29245205.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. Stereotactic Body Radiotherapy for Primary Prostate Cancer. Technol Cancer Res Treat. 2018 01 01; 17:1533033818789633. Kothari G, Loblaw A, Tree AC, van As NJ, Moghanaki D, Lo SS, Ost P, Siva S. PMID: 30064301; PMCID: PMC6069023.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    64. Patient-clinician communication among patients with stage I lung cancer. Support Care Cancer. 2018 May; 26(5):1625-1633. Nugent SM, Golden SE, Thomas CR, Deffebach ME, Sukumar MS, Schipper PH, Tieu BH, Moghanaki D, Wisnivesky J, Slatore C. PMID: 29209835.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    65. Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer. Eur Urol. 2018 07; 74(1):99-106. Ramey SJ, Agrawal S, Abramowitz MC, Moghanaki D, Pisansky TM, Efstathiou JA, Michalski JM, Spratt DE, Hearn JWD, Koontz BF, Liauw SL, Pollack A, Anscher MS, Den RB, Stephans KL, Zietman AL, Lee WR, Stephenson AJ, Tendulkar RD. PMID: 29128208.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    66. Phase 1/2 study of hypofractionated intensity-modulated radiation therapy for prostate cancer including simultaneously integrated boost. Pract Radiat Oncol. 2018 May - Jun; 8(3):e149-e157. Chang MG, Mukhopadhyay N, Holdford D, Skinner V, Saraiya S, Moghanaki D, Anscher MS. PMID: 29290572.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    67. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer. J Thorac Cardiovasc Surg. 2018 01; 155(1):395-402. Cornwell LD, Echeverria AE, Samuelian J, Mayor J, Casal RF, Bakaeen FG, Omer S, Preventza O, Mai W, Chen G, Simpson KH, Moghanaki D, Zhu AW. PMID: 28888379.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    68. Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists. Am J Clin Oncol. 2017 Aug; 40(4):418-422. Lewis SL, Porceddu S, Nakamura N, Palma DA, Lo SS, Hoskin P, Moghanaki D, Chmura SJ, Salama JK. PMID: 25647831.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    69. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017 Sep - Oct; 7(5):295-301. Videtic GMM, Donington J, Giuliani M, Heinzerling J, Karas TZ, Kelsey CR, Lally BE, Latzka K, Lo SS, Moghanaki D, Movsas B, Rimner A, Roach M, Rodrigues G, Shirvani SM, Simone CB, Timmerman R, Daly ME. PMID: 28596092.
      View in: PubMed   Mentions: 184     Fields:    Translation:Humans
    70. Dumping the information bucket: A qualitative study of clinicians caring for patients with early stage non-small cell lung cancer. Patient Educ Couns. 2017 05; 100(5):861-870. Golden SE, Thomas CR, Moghanaki D, Slatore CG, Early Stage Lung Cancer Comparative Effectiveness Research Consortium. PMID: 28034611.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    71. Focusing on the "Person" in Personalized Medicine: The Future of Patient-Centered Care in Radiation Oncology. J Am Coll Radiol. 2016 Dec; 13(12 Pt B):1571-1578. Berman AT, Rosenthal SA, Moghanaki D, Woodhouse KD, Movsas B, Vapiwala N. PMID: 27888944.
      View in: PubMed   Mentions: 8     Fields:    
    72. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. J Clin Oncol. 2016 Oct 20; 34(30):3648-3654. Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ. PMID: 27528718.
      View in: PubMed   Mentions: 129     Fields:    
    73. In Regard to Valle et al. Int J Radiat Oncol Biol Phys. 2016 10 01; 96(2):482-483. Moghanaki D, Timmerman RD, Slatore CG, Niewoehner DE, Karas TZ. PMID: 27598815.
      View in: PubMed   Mentions:    Fields:    
    74. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study. Int J Radiat Oncol Biol Phys. 2016 12 01; 96(5):1046-1053. Pisansky TM, Agrawal S, Hamstra DA, Koontz BF, Liauw SL, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ, Tendulkar RD. PMID: 27745980.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    75. Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer. Acta Oncol. 2016 Dec; 55(12):1500-1502. Anscher MS, Chang MG, Moghanaki D, Rosu M, Mikkelsen RB, Holdford D, Skinner V, Grob BM, Sanyal A, Wang A, Mukhopadhyay ND. PMID: 27582017.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    76. Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning. Semin Radiat Oncol. 2017 01; 27(1):21-33. Moghanaki D, Turkbey B, Vapiwala N, Ehdaie B, Frank SJ, McLaughlin PW, Harisinghani M. PMID: 27986208; PMCID: PMC5743235.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    77. Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer. J Thorac Oncol. 2016 10; 11(10):1672-81. Williams CD, Salama JK, Moghanaki D, Karas TZ, Kelley MJ. PMID: 27296104.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    78. Comparative study of late rectal toxicity in prostate cancer patients treated with low-dose-rate brachytherapy: With or without supplemental external beam radiotherapy. Brachytherapy. 2016 Jul-Aug; 15(4):435-441. Serrano N, Moghanaki D, Asher D, Karlin J, Schutzer M, Chang M, Hagan MP. PMID: 27180124.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    79. Consensus Statement Supporting the Recommendation for Single-Fraction Palliative Radiotherapy for Uncomplicated, Painful Bone Metastases. Fed Pract. 2016 May; 33(Suppl 4):16S-22S. Dawson GA, Moghanaki D, Gutt-Garg R, Hoffman-Hogg L, Kelly M, Cheuk A, Fosmire H, Hagan M. PMID: 30766214; PMCID: PMC6375447.
      View in: PubMed   Mentions:
    80. The Availability of Advanced Radiation Oncology Technology within the Veterans Health Administration Radiation Oncology Centers. Fed Pract. 2016 May; 33(Suppl 4):18S-22S. Dawson GA, Cheuk AV, Lutz S, Gutt-Garg R, Moghanaki D, Jolly S, Kelly MD, Fosmire H, Hoffman-Hogg L, Kemp W, Hagan M. PMID: 30766215; PMCID: PMC6375445.
      View in: PubMed   Mentions: 3  
    81. Is surgery still the optimal treatment for stage I non-small cell lung cancer? Transl Lung Cancer Res. 2016 Apr; 5(2):183-9. Moghanaki D, Chang JY. PMID: 27183993; PMCID: PMC4858582.
      View in: PubMed   Mentions: 7  
    82. Management of Postprostatectomy Biochemical Relapse With Salvage Radiotherapy: Results of an International Survey. Am J Clin Oncol. 2016 Feb; 39(1):64-8. Moghanaki D, Urdaneta AI, Karlin JD, Koontz BF, Anscher MS. PMID: 24390275.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    83. In Reply to Mell. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):468-9. Vapiwala N, Moghanaki D, Movsas B. PMID: 26383686.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    84. Patient autonomy and shared decision making in the management of urethral cancer. Pract Radiat Oncol. 2016 Jan-Feb; 6(1):66-70. Serrano N, Chang M, Leland Rogers C, Orton M, Mannino R, Grob M, Agarwal R, Moghanaki D. PMID: 26577009.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Cultivating Tomorrow's Clinician Scientists: We Reap What We Sow. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):206-10. Vapiwala N, Moghanaki D, Movsas B. PMID: 25968819.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    86. Palliative Radiotherapy for the Management of Metastatic Cancer: Bone Metastases, Spinal Cord Compression, and Brain Metastases. Fed Pract. 2015 May; 32(Suppl 4):12S-16S. Gutt R, Dawson G, Cheuk AV, Fosmire H, Moghanaki D, Kelly M, Jolly S. PMID: 30766118; PMCID: PMC6375451.
      View in: PubMed   Mentions: 5  
    87. A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers. Prostate Cancer Prostatic Dis. 2015 Jun; 18(2):96-103. Schutzer ME, Orio PF, Biagioli MC, Asher DA, Lomas H, Moghanaki D. PMID: 25687401.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    88. Clinic offering affordable radiation therapy to increase access to care for patients enrolled in hospice. J Oncol Pract. 2014 Nov; 10(6):e390-5. Schuster JM, Smith TJ, Coyne PJ, Lutz S, Anscher MS, Moghanaki D. PMID: 25271245.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    89. Availability of single-fraction palliative radiotherapy for cancer patients receiving end-of-life care within the Veterans Healthcare Administration. J Palliat Med. 2014 Nov; 17(11):1221-5. Moghanaki D, Cheuk AV, Fosmire H, Anscher MS, Lutz ST, Hagan MP, Dawson GA, U.S. Veterans Healthcare Administration National Palliative Radiotherapy Taskforce. PMID: 25188468.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    90. Surgery versus SABR for NSCLC. Lancet Oncol. 2013 Nov; 14(12):e490-1. Moghanaki D, Karas T. PMID: 24176566.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    91. Prostate cancer: should men with metastases undergo radical prostatectomy? Nat Rev Urol. 2013 Sep; 10(9):501-2. Moghanaki D, Anscher MS. PMID: 23857177.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    92. The value of an educational video before consultation with a radiation oncologist. J Cancer Educ. 2013 Jun; 28(2):306-13. Matsuyama RK, Lyckholm LJ, Molisani A, Moghanaki D. PMID: 23526553; PMCID: PMC4851426.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    93. Identifying appropriate patients for early salvage radiotherapy after prostatectomy. J Urol. 2013 Oct; 190(4):1410-5. Karlin JD, Koontz BF, Freedland SJ, Moul JW, Grob BM, Wan W, Hagan MP, Anscher MS, Moghanaki D. PMID: 23648223.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    94. Re: Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis. Int J Urol. 2013 May; 20(5):547-8. Moghanaki D, Freedland SJ, Anscher M. PMID: 23094757.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy. Cancer. 2013 Jan 01; 119(1):52-60. Moghanaki D, Koontz BF, Karlin JD, Wan W, Mukhopadhay N, Hagan MP, Anscher MS. PMID: 22736478.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    96. Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma. JOP. 2011 Sep 09; 12(5):438-44. Moghanaki D, Mick R, Furth EE, Sohal D, Salmon PM, Behbahani A, Morgans AK, Miller SM, Giantonio BJ, Whittington RW, Haller DG, Rosato EF, Plastaras JP. PMID: 21904068.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    97. Education level, not health literacy, associated with information needs for patients with cancer. Patient Educ Couns. 2011 Dec; 85(3):e229-36. Matsuyama RK, Wilson-Genderson M, Kuhn L, Moghanaki D, Vachhani H, Paasche-Orlow M. PMID: 21543182.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    98. Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next? Clin Colorectal Cancer. 2009 Oct; 8(4):194-9. Weiss J, Moghanaki D, Plastaras JP, Haller DG. PMID: 19822509.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    99. Denis Parsons Burkitt, FRSM, FRCS (Edinburgh): a passion for learning. J Pediatr Hematol Oncol. 2008 Oct; 30(10):754-7. Moghanaki D. PMID: 19011473.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J Immunol. 2005 Jan 01; 174(1):215-22. Dikov MM, Ohm JE, Ray N, Tchekneva EE, Burlison J, Moghanaki D, Nadaf S, Carbone DP. PMID: 15611243.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansAnimalsCells
    101. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Mol Cancer Ther. 2004 Aug; 3(8):941-53. Maglione JE, McGoldrick ET, Young LJ, Namba R, Gregg JP, Liu L, Moghanaki D, Ellies LG, Borowsky AD, Cardiff RD, MacLeod CL. PMID: 15299077.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    102. Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res. 2001 Nov 15; 61(22):8298-305. Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL. PMID: 11719463.
      View in: PubMed   Mentions: 141     Fields:    Translation:AnimalsCells
    103. Genetically engineered mouse models of mammary intraepithelial neoplasia. J Mammary Gland Biol Neoplasia. 2000 Oct; 5(4):421-37. Cardiff RD, Moghanaki D, Jensen RA. PMID: 14973386.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    Drew's Networks
    Concepts (263)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (33)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California